Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) Quick Ratio (Acid-Test): 1.51

Is Danaher Corporation’s quick ratio (acid-test) high or low?

Danaher Corporation's quick ratio (acid-test) of 1.51 is 11% above its 5-year average of 1.36, near the high end of its 5-year range (1.05–1.56).

The quick ratio (acid-test) for Danaher Corporation (DHR) is 1.51 as of Wednesday, June 10, 2026. It is above its 12-month average by 17.97% (1.28).

DHR Quick Ratio (Acid-Test) Chart

DHR Quick Ratio (Acid-Test)
1.51+43.81% 1Y
Zoom

DHR Average Quick Ratio (Acid-Test) Chart

DHR Current vs Average Quick Ratio (Acid-Test) Chart

DHR Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.51

QUICK RATIO (ACID-TEST) AVG TTM

1.28

QUICK RATIO (ACID-TEST) AVG 3Y

1.37

QUICK RATIO (ACID-TEST) AVG 5Y

1.36

QUICK RATIO (ACID-TEST) AVG 10Y

1.54

QUICK RATIO (ACID-TEST) AVG 15Y

1.48

QUICK RATIO (ACID-TEST) AVG 20Y

1.39

CURRENT VS TTM AVG

+17.97%

CURRENT VS 3Y AVG

+10.02%

CURRENT VS 5Y AVG

+11.44%

CURRENT VS 10Y AVG

-1.77%

CURRENT VS 15Y AVG

+1.77%

CURRENT VS 20Y AVG

+8.37%

DHR Competitors' Quick Ratio (Acid-Test)

NAMEMARKET CAPQUICK RATIO (ACID-TEST)TTM3Y5Y
Danaher Corporation (DHR)$130.25B1.511.281.371.36
CVS Health Corporation (CVS)$125.16B0.630.610.630.63
Bristol-Myers Squibb Company (BMY)$114.14B1.141.151.191.27
Pfizer Inc. (PFE)$146.36B0.870.900.870.95
Intuitive Surgical, Inc. (ISRG)$146.44B3.963.593.744.30
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B2.462.413.313.62
Gilead Sciences, Inc. (GILD)$151.21B1.311.381.291.26
Abbott Laboratories (ABT)$154.66B1.181.211.201.26
Medtronic plc (MDT)$103.04B0.001.481.571.68
Elevance Health Inc. (ELV)$87.43B1.241.171.081.07

Liquidity Comparison

Quick Ratio

1.51

Excludes inventory

Current Ratio

1.87

Includes inventory

Danaher Corporation Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio = (Current Assets − Inventory) / Current Liabilities

The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Danaher Corporation (DHR)?
The quick ratio (acid-test) for DHR stock is 1.51.
Is Danaher Corporation's quick ratio (acid-test) high or low?
Danaher Corporation's quick ratio (acid-test) of 1.51 is 11% above its 5-year average of 1.36, near the high end of its 5-year range (1.05–1.56).
What is the TTM average quick ratio (acid-test) for Danaher Corporation (DHR)?
The TTM average quick ratio (acid-test) for DHR stock is 1.28.
What is the 3Y average quick ratio (acid-test) for Danaher Corporation (DHR)?
The 3Y average quick ratio (acid-test) for DHR stock is 1.37.
What is the 5Y average quick ratio (acid-test) for Danaher Corporation (DHR)?
The 5Y average quick ratio (acid-test) for DHR stock is 1.36.
What is the 10Y average quick ratio (acid-test) for Danaher Corporation (DHR)?
The 10Y average quick ratio (acid-test) for DHR stock is 1.54.
What is the 15Y average quick ratio (acid-test) for Danaher Corporation (DHR)?
The 15Y average quick ratio (acid-test) for DHR stock is 1.48.
What is the 20Y average quick ratio (acid-test) for Danaher Corporation (DHR)?
The 20Y average quick ratio (acid-test) for DHR stock is 1.39.

Danaher Corporation Quick Ratio (Acid-Test) History

DATEQUICK RATIO (ACID-TEST)
2025-12-311.51
2024-12-311.05
2023-12-311.37
2022-12-311.56
2021-12-311.09
2020-12-311.55
2019-12-314.86
2018-12-311.13
2017-12-311.05
2016-12-310.72
2015-12-311.02
2014-12-311.41
2013-12-311.61
2012-12-311.37
2011-12-311.08
2010-12-311.36
2009-12-311.53
2008-12-311.11
2007-12-310.98
2006-12-310.97
2005-12-310.93
2004-12-311.01
2003-12-311.74
2002-12-311.50
2001-12-311.44
2000-12-311.00
1999-12-311.24
1998-12-310.82
1997-12-310.78
1996-12-310.72

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair